Skip to main content

Table 5 Adjusted models explaining mortality within 30 days in the ICU

From: Dysglycemias in patients admitted to ICUs with severe acute respiratory syndrome due to COVID-19 versus other causes - a cohort study

Multivariate explanatory models of mortality in the overall cohort

n#

OR (95% CI) adjusted*

p value §

BIC ‡

Highest glucose level at admission

833

1.004 (1.002–1.006)

< 0.001

847.026

COVID-19 (ref: non-COVID-19)

2.990 (1.767–5.060)

< 0.001

History of diabetes (ref: no history)

0.658 (0.435–0.995)

0.048

Age

1.026 (1.013–1.038)

< 0.001

APACHE II score

1.057 (1.032–1.082)

< 0.001

SOFA score in the first 24 h

1.299 (1.201–1.405)

< 0.001

CRP level in the first 24 h

1.004 (1.002–1.006)

< 0.001

Highest glucose level during ICU stay

837

1.003 (1.000–1.005)

0.021

519.168

COVID-19 (ref: non-COVID-19)

2.655 (1.363–5.17)

0.004

History of diabetes (ref: no history)

0.816 (0.458–1.457)

0.493

Age

1.020 (1.003–1.037)

0.023

APACHE II score

0.997 (0.966–1.028)

0.847

Nosocomial infection (ref: no infection)

0.976 (0.558–1.707)

0.933

Mean SOFA score

2.327 (1.993–2.717)

< 0.001

Mean CRP level

1.010 (1.006–1.013)

< 0.001

Mean glucose level during ICU stay

837

1.011 (1.006–1.016)

< 0.001

502.875

COVID-19 (ref: non-COVID-19)

2.665 (1.336–5.315)

0.005

History of diabetes (ref: no history)

0.566 (0.312–1.029)

0.062

Age

1.024 (1.006–1.041)

0.009

APACHE II score

0.993 (0.962–1.026)

0.684

Nosocomial infection (ref: absent)

1.080 (0.630–1.851)

0.779

Mean SOFA score

2.348 (2.014–2.737)

< 0.001

Mean CRP level

1.01 (1.006–1.014)

< 0.001

% of days with hyperglycemia (≥ 180 mg/dL)

837

1.017 (1.010–1.025)

< 0.001

504.526

COVID-19 (ref: non-COVID-19)

2.350 (1.192–4.633)

0.014

History of diabetes (ref: no history)

0.555 (0.302–1.019)

0.058

Age

1.020 (1.003–1.038)

0.020

APACHE II score

0.993 (0.962–1.025)

0.669

Nosocomial infection (Ref: absent)

1.010 (0.588–1.734)

0.971

Mean SOFA score

2.370 (2.032–2.765)

< 0.001

Mean CRP level

1.010 (1.006–1.014)

< 0.001

Mean glucose variability (CV %) during ICU stay

762

1.032 (1.013–1.051)

0.001

476.005

COVID-19 (ref: non-COVID-19)

3.126 (1.503–6.502)

0.002

History of diabetes (ref: no history)

0.651 (0.347–1.222)

0.181

Age

1.022 (1.004–1.04)

0.015

APACHE II score

0.984 (0.951–1.017)

0.329

Nosocomial infection (ref: no infection)

1.235 (0.716–2.13)

0.449

Mean SOFA score

2.444 (2.079–2.873)

0.000

Mean CRP level

1.010 (1.006–1.014)

0.000

  1. Abbreviations: APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; CRP, C-reactive protein (mg/L)
  2. #Case numbers included in the model
  3. * Odds ratio (OR) and 95% confidence interval (95% CI) for mortality within 30 days in the ICU, generalized linear models with multivariate binary logistic regression
  4. §Wald test p value, with values < 0.05 indicating statistical significance
  5. Bayesian information criterion (BIC) of the multivariate generalized linear model representing the quality of the model given its explanatory potential; the lower the BIC, the more the model is able to explain the dependent variable